AACR colorectal cancer conference to focus on screening, new treatments
The American Association for Cancer Research will hosts its first special conference on Colorectal Cancer: Biology to Therapy from Oct. 27-30, 2010, at the Loews Hotel, Philadelphia.
Colorectal cancer is the third leading cause of cancer in men and women. While screening has brought mortality rates down, much work remains to be done.
"Colorectal cancer is still one of the deadliest cancers, and our current screening methods are not yet always efficient or complete," said Anil Rustgi, M.D., chief of gastroenterology, T. Grier Miller Professor of Medicine and Genetics, and American Cancer Society Professor at the University of Pennsylvania School of Medicine and a program chairperson of the AACR special conference.
Rustgi will host a press conference on Thursday, Oct. 28 at 1:00 p.m. ET in the Adams Room on the third floor of the Loews Hotel in Philadelphia. The press conference will feature the following new research:
- Telomere Length Affects Colorectal Cancer Risk
- New Colorectal Screening Test Measures DNA Methylation
- FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability
- Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer
Reporters who cannot attend in person can participate using the following information:
Dial-in (U.S. and Canada): (888) 282-7404
Dial-in (International): (706) 679-5207
Access Code: 18304706
The American Association for Cancer Research Communications Department has also identified the following research as newsworthy:
- Researchers Build Colony of Colon Cancer Stem Cells to Test New Approach to Therapy
- Small-molecule Inhibitors Effectively Targeted Active Colon Cancer Enzyme
Provided by American Association for Cancer Research
